公司新闻 - 亚科因(Abbkine)—服务于细胞和蛋白研究全球用户
加入收藏 欢迎光临Abbkine Scientific Co., Ltd官方网站全国服务热线:400-6800-830
登录 注册
中文

亚科因(Abbkine)—服务于细胞和蛋白研究全球用户

货号 产品名称 文献标题 IF 杂志名称
BMU102 SuperKine™ 超敏型ECL发光液(飞克级) Using computational pharmacology and experimental verification to decode mechanism of Qing-Wei-San in treating periodontitis. 3 BMC Complementary Medicine and Therapies 
BMU102 SuperKine™ 超敏型ECL发光液(飞克级) P4HB, a novel succinated protein, is essential for fumarate-induced cancer metastasis. 8 International Journal of Biological Macromolecules
BMU102 SuperKine™ 超敏型ECL发光液(飞克级) HSPB6 based on integrative multi-omics analysis can suppress colorectal cancer progression by downregulating HSPA6 expression through the JNK-JUND axis 5 Chemical Engineering Journal
BMU102 SuperKine™ 超敏型ECL发光液(飞克级) Mechanism of Huaiqihuang in treatment of diabetic kidney disease based on network pharmacology, molecular docking and in vitro experiment 2 Drug Des Devel Ther
BMU102 SuperKine™ 超敏型ECL发光液(飞克级) Network pharmacology and in vitro experiments reveal the potencial mechanism of Qizhiyishen Decoction against AKI. Available at SSRN
BMU102 SuperKine™ 超敏型ECL发光液(飞克级) Glycated ECM Derived Carbon Dots Inhibit Tumor Vasculogenic Mimicry by Disrupting RAGE Nuclear Translocation and Its Interaction With HMGB1. 27 Advanced Materials 
BMU102 SuperKine™ 超敏型ECL发光液(飞克级) Activation Of Endothelial Transient Receptor Potential Vanilloid 4 Exacerbates Myocardial Ischemia-Reperfusion Injury Via Vascular Integrity Impairment.
BMU102 SuperKine™ 超敏型ECL发光液(飞克级) CX‑5461 potentiates imatinib‑induced apoptosis in K562 cells by stimulating KIF1B expression. 2 Experimental and Therapeutic Medicine
BMU102 SuperKine™ 超敏型ECL发光液(飞克级) Sodium Tanshinone IIA Sulfonate alleviates vascular senescence in diabetic mice by modulating the A20-NFκB-NLRP3 inflammasome-catalase pathway. 4 Scientific Reports
BMU102 SuperKine™ 超敏型ECL发光液(飞克级) Single‐Cell Transcriptome Profiling Reveals Conserved IFNγ‐IL8 Signaling‐Induced Antibacterial Neutrophil States during Bacterial Infection. 14 Advanced Science
意见反馈
在线咨询
扫码关注

微信公众号

返回顶部